Furthermore, we applied these techniques in breast cancer tissues in order to use the obtained quantitative data to determine any existing significant correlation between the differential expression of COL11A1 variants and clinicopathological features of these patients. The gene discussed is COL11A1; the disease is breast carcinoma.